Loading clinical trials...
Loading clinical trials...
RATIONALE: Lymphatic mapping may improve the ability to detect cancer of the vulva. PURPOSE: This phase III trial is studying how well lymphatic mapping works in treating patients with stage I or sta...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Gynecologic Oncology Group
Collaborators
NCT05639972 · HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, and more
NCT06639191 · Thyroid Gland Anaplastic Carcinoma, Poorly Differentiated Thyroid Carcinoma, and more
NCT06447064 · Pancreatic Cancer, Colon Cancer, and more
NCT06339827 · Ovarian Cancer, Endometrial Cancer, and more
NCT05979610 · Gynecologic Neoplasm, Brachytherapy, and more
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas
Todd Cancer Institute at Long Beach Memorial Medical Center
Long Beach, California
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions